These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5421370)

  • 1. [Mass screening and cancer].
    Saxen E
    Duodecim; 1970; 86(5):265-7. PubMed ID: 5421370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cervical cancer and mass screening].
    Hakama M
    Duodecim; 1970; 86(5):270-6. PubMed ID: 5421372
    [No Abstract]   [Full Text] [Related]  

  • 3. The cancer registry in cancer control.
    Saxén EA
    Arch Geschwulstforsch; 1984; 54(5):403-8. PubMed ID: 6497585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervix neoplasms and mass screening].
    Hakama M
    Duodecim; 1970; 86(9):528-35. PubMed ID: 5463389
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening for cancer still useful and effective].
    Teppo L; Anttila A; Auvinen A; Hakama M
    Duodecim; 2000; 116(8):893-901. PubMed ID: 11787133
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer incidence in Finland with a note on difficulties in comparing epidemiological data.
    Saxén E; Hakama M
    Cancro; 1966; 19(2):88-96. PubMed ID: 5973756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carcinoma of the uterine cervix and mass screening].
    Timonen S; Nieminen U
    Duodecim; 1970; 86(5):277-84. PubMed ID: 5421373
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancer screening in Hungary: World Bank supported model programs].
    Bodó M; Döbrössy L; Liszka G; Ottó S; Péter Z
    Orv Hetil; 1997 Jul; 138(28):1801-4. PubMed ID: 9280875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in cervical cancer mass screening results in Greater-Helsinki area].
    Nieminen P; Tarkkanen J; Timonen T; Meyer B; Hakama M; Anttila A
    Duodecim; 2000; 116(22):2489-96. PubMed ID: 12053343
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer screening].
    Akaza H; Tsuruo T; Saijo N; Sone S; Isonishi S; Ohashi Y; Sobue T; Yamanaka H; Fukuda M; Maruyama M; Eguchi K; Ito K; Smith M; Milsted B
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):125-34. PubMed ID: 15675598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of cancer registries in the evaluation of breast cancer screening].
    Schaffer P; Renaud R; Gairard B; Guldenfels C
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S15-21. PubMed ID: 8935860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft.
    Lund E; Dumeaux V; Braaten T; Hjartåker A; Engeset D; Skeie G; Kumle M
    Int J Epidemiol; 2008 Feb; 37(1):36-41. PubMed ID: 17644530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Janus project].
    Torgersen O
    Tidsskr Nor Laegeforen; 1975 Oct; 95(28):1611-3. PubMed ID: 1179396
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer screening in general practice.
    Fahridin S; Britt H
    Aust Fam Physician; 2009 Apr; 38(4):187. PubMed ID: 19350065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
    Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
    Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European randomized study of prostate cancer screening: first-year results of the Finnish trial.
    Määttänen L; Auvinen A; Stenman UH; Rannikko S; Tammela T; Aro J; Juusela H; Hakama M
    Br J Cancer; 1999 Mar; 79(7-8):1210-4. PubMed ID: 10098761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The trade-off between population and individual benefit of screening.
    Hense HW
    Z Arztl Fortbild Qualitatssich; 2006; 100(7):505-13. PubMed ID: 17137063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.